CD30 monoclonal antibodies 

What are CD30 monoclonal antibodies?

Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. The complex can be recognized and destroyed by phagocytes or used for other diagnostic purposes. CD30 has been identified as a marker on Reed–Sternberg cells in Hodgkin lymphoma and cells in other specific types of lymphoma. CD30 monoclonal antibodies may be used to treat Hodgkin’s lymphoma or anaplastic large cell lymphoma.

An anti-CD3 monoclonal antibody is one that binds to CD3 on the surface of T cells. They are immunosuppresive drugs. The first to be approved was muromonab-CD3 in 1986, to treat transplant rejection. Newer monoclonal antibodies with the same mechanism of action include otelixizumab, teplizumab and visilizumab.

CD30 is a surface marker for neoplastic cells of Hodgkin’s lymphoma and shows sequence homology to members of the tumor necrosis factor (TNF) receptor superfamily.

List of CD30 monoclonal antibodies

Cabenuva

Cabenuva

Cabometyx

Cabometyx

Calcitriol

Calcitriol

Calquence

Calquence

Camzyos

Camzyos

Canasa

Canasa

Candesartan

Candesartan

Caplyta

Caplyta

Captopril

Captopril

Carvedilol

Carvedilol

Carvykti

Carvykti

Casodex

Casodex

Cefdinir

Cefdinir

Cefixime

Cefixime

Ceftriaxone

Ceftriaxone

Celebrex

Celebrex

Celecoxib

Celecoxib

Celexa

Celexa

Cephalexin

Cephalexin

Cetirizine

Cetirizine

Cialis

Cialis

Cimzia

Cimzia

Cinryze

Cinryze

Cipro

Cipro

Citalopram

Citalopram

Claritin

Claritin

Clindamycin

Clindamycin

Clobetasol

Clobetasol

Clobex

Clobex

Clodan

Clodan

Clonazepam

Clonazepam

Clopidogrel

Clopidogrel

Clotrimazole

Clotrimazole

Clozapine

Clozapine

Cobenfy

Cobenfy

Codeine

Codeine

Colace

Colace

Colazal

Colazal

Colchicine

Colchicine

Concerta

Concerta

Coreg

Coreg

Crestor

Crestor